Hi Plum
Not sure what you mean here - which results from which trial for which drug - or who "mentioned" that.
None of the current clinical trials are complete, so there will be no "full presentation of results on the 26th May."
Interim trial results are released as they become available, but IMU does often (though not always) present key data at major conferences. When that is the case, an Announcement to the ASX is timed to coincide with the release of information at the Conference. Up until that point, the conference presentation is embargoed.
Holding IMU (or any Biotech) is a test of patience. The time frame can seem long, and in between results the negative chatter on HC builds - but so far the results from all trials have been positive. Informal comments from the IMU team have been extremely upbeat.
It remains speculative, but the potential reward for success (or multiple successes) is enormous. The magnitude of the failure risk varies depending who you listen to.
Cheers
Dave
The CF33, Vaxinia and Oncarlytics Deal, page-546
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.1¢ |
Change
-0.003(6.82%) |
Mkt cap ! $304.9M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.4¢ | 4.1¢ | $1.607M | 38.52M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 4542680 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.3¢ | 1675759 | 9 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |